Company Filing History:
Years Active: 2017
Title: The Innovative Contributions of Jaw-Wen Chen
Introduction
Jaw-Wen Chen is a prominent inventor based in Taipei, Taiwan. He has made significant contributions to the field of medicine, particularly in the treatment of hypertension. His innovative approach has the potential to improve the quality of life for many individuals suffering from this condition.
Latest Patents
Jaw-Wen Chen holds a patent for a method of treating hypertension. The patent describes the use of dextromethorphan to lower blood pressure in subjects suffering from hypertension, either alone or in combination with another anti-hypertensive agent. Notably, dextromethorphan acts synergistically with calcium channel blockers, such as amlodipine, leading to a major improvement in hypertension treatment with minimal adverse effects. This patent highlights his commitment to advancing medical treatments.
Career Highlights
Chen is associated with Tsh Biopharm Corporation Ltd., where he continues to work on innovative solutions in the pharmaceutical industry. His dedication to research and development has positioned him as a key figure in the field of hypertension treatment.
Collaborations
Some of his notable coworkers include Hsi-Chieh Wang and Shin-Yi Juang. Their collaborative efforts contribute to the ongoing advancements in medical research and innovation.
Conclusion
Jaw-Wen Chen's work exemplifies the impact of innovation in medicine, particularly in the treatment of hypertension. His contributions are paving the way for more effective therapies that can enhance patient outcomes.